Targeted Exercise Prescription for Cardiac Rehabilitation
(PACE SETTER Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests two different exercise plans to determine which is more effective for people recovering from heart problems. One plan, called GXT+THHR (Graded Exercise Test + Target Heart Rate Range Prescription), uses a heart rate test to set exercise goals. The other, known as RPE (Rating of Perceived Exertion), relies on how hard the exercise feels to the participant. The trial also examines how feedback during exercise might enhance fitness. People who have experienced a heart issue, such as a heart attack or surgery in the last six months, and live in the Springfield, MA, or Detroit, MI, area might be suitable candidates. Participants must attend at least 18 cardiac rehab sessions and agree to exercise regularly. As a Phase 2 trial, this research measures the effectiveness of the exercise plans in an initial, smaller group, offering participants a chance to contribute to important findings in heart recovery.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that these exercise prescriptions are safe for cardiac rehabilitation?
Research has shown that the GXT+THHR method, which includes a graded exercise test and a target heart rate range, has been generally well-tolerated in past studies. Participants who followed this exercise plan did not experience serious side effects. Some minor issues, such as temporary muscle soreness or tiredness, were noted, which are common when starting new exercise routines. This method tailors exercise intensity to each person, aiming to improve heart health safely. It is important to know that this approach remains under investigation, with researchers closely monitoring its safety and effectiveness. This stage of research indicates that while the treatment appears promising, scientists are still gathering detailed safety information.12345
Why are researchers excited about this trial?
Researchers are excited about this trial because it explores a new approach to cardiac rehabilitation by using a targeted exercise prescription. Unlike the standard method, which relies on perceived exertion (RPE) to guide exercise intensity, the intervention uses a graded exercise test (GXT) to determine a personalized target heart rate range (THRR). This THRR, calculated using the Karvonen formula, allows for a more precise regulation of exercise intensity, potentially improving outcomes. By focusing on individual heart rate data, this method could enhance the effectiveness of cardiac rehabilitation by optimizing exercise intensity and personalizing patient care.
What evidence suggests that this trial's exercise prescriptions could be effective for cardiac rehabilitation?
Research has shown that using a Graded Exercise Test (GXT) to set a target heart rate for exercise in cardiac rehabilitation improves fitness levels more effectively. In this trial, participants in the GXT+THHR arm will follow this method, which creates a personalized exercise plan, making it easier to exercise at the right intensity. Studies have found that people using this method often feel less afraid of exercising and more confident in their ability to do so. Conversely, participants in the RPE arm will follow the standard method, which uses Rating of Perceived Exertion (RPE) and relies on individuals estimating their own exercise intensity, which can be less accurate. Early evidence suggests that the GXT+THHR approach may lead to better exercise results and possibly long-term health benefits.12356
Who Is on the Research Team?
Quinn Pack, MD
Principal Investigator
Baystate Medical Center
Are You a Good Fit for This Trial?
This trial is for older adults (60+) who've had a recent heart event like a heart attack, bypass surgery, or valve replacement and are eligible for cardiac rehab. They must live near Springfield, MA or Detroit, MI and commit to at least 18 rehab sessions.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Participants undergo baseline assessments including 6MWT, SPPB, and psychological assessments
Treatment
Participants attend at least 18 sessions of cardiac rehabilitation, randomized to either GXT-THRR or RPE
Follow-up
Participants are monitored for long-term clinical outcomes and changes in physical performance
What Are the Treatments Tested in This Trial?
Interventions
- GXT+THHR
- RPE
GXT+THHR is already approved in United States for the following indications:
Find a Clinic Near You
Who Is Running the Clinical Trial?
Baystate Medical Center
Lead Sponsor
Rutgers, The State University of New Jersey
Collaborator
Springfield College
Collaborator
University of Pennsylvania
Collaborator
Henry Ford Hospital
Collaborator